Are you ready to solve some of the biggest challenges of our time?
Biogen and VTT Technical Research Centre of Finland call for start-up and scaleup companies working on a digital health solution to be part of the solution and apply to our “Alzheimer’s Disease Challenge” workshop at the world’s leading start-up conference, Slush, on December 1, 2021 in Helsinki.
In the Alzheimer’s Disease Challenge workshop, we will be going deeper into the specific challenges related to different parts of Alzheimer’s patient journey. The challenges include but are not limited to digital solution
• prevention and early detection of Alzheimer’s Disease
• patient and care giver support
• healthcare system support in Alzheimer’s Disease management
The workshop will be facilitated by Biogen and VTT teams together with leading AD experts and representatives from a VC fund. The workshop is focused on building a pathway towards implementation of your technology in real healthcare setting so that it can benefit AD patients and their loved ones as soon as possible.
Getting excited? So are we!
Apply here by 31.10.2021. Start-ups to the workshop will be notified by November 15th latest. Selected start-ups will be provided with a Slush pass.
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies.
VTT is one of Europe’s leading research institutions, owned by the Finnish state. VTT aims to advance the utilization and commercialization of research and technology. Through scientific and technological means, we turn large global challenges into sustainable growth for businesses and society.